# Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients

> **NCT01672463** · PHASE1 · UNKNOWN · sponsor: **Oblato, Inc.** · enrollment: 31 (estimated)

## Conditions studied

- Recurrent Malignant Glioma

## Interventions

- **DRUG:** OKN-007

## Key facts

- **NCT ID:** NCT01672463
- **Lead sponsor:** Oblato, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-10
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01672463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01672463, "Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01672463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*